Tanshinone IIA inhibits Leu27IGF‐II ‐induced insulin‐like growth factor receptor II signaling and myocardial apoptosis via estrogen receptor‐mediated Akt activation

Author:

Chou Shui Lian1,Ramesh Samiraj23,Kuo Chia‐Hua4,Ali Ayaz2,Ho Tsung‐Jung56,Chang Ko Peng1,Hsieh Dennis Jine‐Yuan78,Kumar V. Bharath9,Weng Yueh‐Shan10,Kuo Wei‐Wen1011ORCID,Huang Chih‐Yang29121314ORCID

Affiliation:

1. Department of Family Medicine Jen‐Ai Hospital Taichung Taiwan

2. Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Tzu Chi University of Science and Technology Hualien Taiwan

3. Department of Microbiology PRIST Deemed to be University Thanjavur Tamil Nadu India

4. Department of Sports Sciences University of Taipei Taipei Taiwan

5. Chinese Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Tzu Chi University Hualien Taiwan

6. Integration Center of Traditional Chinese and Modern Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Tzu Chi University of Science and Technology Hualien Taiwan

7. School of Medical Laboratory and Biotechnology Chung Shan Medical University Taichung Taiwan

8. Clinical Laboratory Chung Shan Medical University Hospital Taichung Taiwan

9. Department of Medical Laboratory Science and Biotechnology Asia University Taichung Taiwan

10. Department of Biological Science and Technology College of Life Sciences, China Medical University Taichung Taiwan

11. Ph.D. Program for Biotechnology Industry China Medical University Taichuang Taiwan

12. Department of Medical Research, China Medical University Hospital China Medical University Taichung Taiwan

13. Graduate Institute of Biomedical Science China Medical University Taichung Taiwan

14. Center of General Education, Buddhist Tzu Chi Medical Foundation Tzu Chi University of Science and Technology Hualien Taiwan

Funder

China Medical University, Taiwan

Asia University

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Management, Monitoring, Policy and Law,Toxicology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3